Congratulations to Ortho Clinical Diagnostics on a Successful IPO!
Congratulations to the entire management team at our client, Ortho Clinical Diagnostics Holdings, a global leader of in-vitro diagnostics dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, on their successful IPO. Trading under the “OCDX” ticker, investors can now invest in the bright future of of a market leader! Alpha is proud to have assisted the team in the many phases of the IPO including planning, execution, and post-IPO planning. We look forward to assisting the Ortho team as they continue to grow and develop new medical solutions.